{"id":59089,"date":"2024-02-28T05:41:40","date_gmt":"2024-02-28T05:41:40","guid":{"rendered":"https:\/\/medsname.com\/mirago\/"},"modified":"2026-04-30T10:24:04","modified_gmt":"2026-04-30T10:24:04","slug":"mirago","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/mirago\/","title":{"rendered":"Mirago"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:18px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin-top:0;color:#8a5a00;\">R\u0103spuns rapid \u2014 Ce este Mirago?<\/h3>\n<p style=\"margin:0;font-size:15px;line-height:1.6;\"><strong>Mirago<\/strong> con\u021bine <strong>mirabegron 25 mg<\/strong> (comprimat cu eliberare prelungit\u0103) \u2014 primul din clas\u0103 <strong>agonist al receptorului adrenergic beta-3 (\u03b23)<\/strong> pentru tratamentul <strong>vezic\u0103 hiperactiv\u0103 (OAB)<\/strong>. Spre deosebire de medicamentele anticholinergice mai vechi pentru OAB (oxibutinin\u0103, tolterodin\u0103, solifenacin\u0103), mirabegron ac\u021bioneaz\u0103 prin relaxarea mu\u0219chiului neted detrusor \u00ceN TIMPUL umplerii vezicii urinare, \u00een loc s\u0103 blocheze receptorii de acetilcolin\u0103. Rezultatul: eficacitate similar\u0103 f\u0103r\u0103 efectele adverse de gur\u0103 uscat\u0103, constipa\u021bie, vedere \u00eence\u021bo\u0219at\u0103, \u00eencetinire cognitiv\u0103 \u0219i risc de c\u0103dere care limiteaz\u0103 utilizarea anticholinergicelor la pacien\u021bii \u00een v\u00e2rst\u0103. Doza standard: <strong>un comprimat de 25 mg o dat\u0103 pe zi<\/strong>; poate fi crescut\u0103 la 50 mg\/zi dup\u0103 4-8 s\u0103pt\u0103m\u00e2ni dac\u0103 r\u0103spunsul este insuficient. Poate fi luat cu sau f\u0103r\u0103 alimente. Criteriile Beers 2023 ale Societ\u0103\u021bii Americane de Geriatrie clasific\u0103 toate medicamentele anticholinergice pentru OAB drept <strong>\u201cpoten\u021bial inadecvate\u201d la adul\u021bii cu v\u00e2rsta de 65+ ani<\/strong> \u2014 f\u0103c\u00e2nd din mirabegron medicamentul de prim\u0103 linie preferat pentru OAB \u00een aceast\u0103 popula\u021bie. <strong>Efecte secundare cele mai frecvente:<\/strong> cre\u0219tere u\u0219oar\u0103 a tensiunii arteriale (monitorizarea TA la \u00eenceput), tahicardie, infec\u021bie a tractului urinar, cefalee, nazofaringit\u0103. <strong>Contraindicate \u00een hipertensiune sever\u0103 necontrolat\u0103<\/strong>.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<div style=\"background:#f4f8fb;border:1px solid #d6e4ec;padding:12px 18px;margin:14px 0;border-radius:4px;font-size:14px;color:#3a5160;text-align:center;\">\n<strong>\ud83d\udd12 Checkout criptat<\/strong> \u00b7 <strong>\ud83d\udcb3 Procesor verificat<\/strong> \u00b7 <strong>\ud83d\ude9a Livrare worldwide<\/strong> \u00b7 <strong>\u2b50 4,9\/5 de la peste 1.400 de clien\u021bi<\/strong>\n<\/div>\n<p><!-- medsbase-why-order --><\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Fiecare lot este procurat de la un <strong>produc\u0103tor certificat WHO-GMP<\/strong>. Comenzile sunt expediate \u00een ambalaje simple, f\u0103r\u0103 marc\u0103, de la partenerii no\u0219tri de onorare \u0219i acoperite de <a href=\"\/ro\/medsbase-re-shipment-assurance-policy\/\">Politica noastr\u0103 de Reexpediere Garantat\u0103<\/a>: dac\u0103 un colet nu ajunge \u00een 20 de zile lucr\u0103toare, trimitem gratuit o nou\u0103 comand\u0103, f\u0103r\u0103 \u00eentreb\u0103ri.<\/p>\n<div style=\"background:#fafafa;border:1px solid #e0e0e0;padding:16px 20px;margin:18px 0;border-radius:4px;\">\n<strong style=\"display:block;margin-bottom:8px;color:#333;\">Pe aceast\u0103 pagin\u0103<\/strong><\/p>\n<ul style=\"margin:0;padding-left:20px;line-height:1.8;\">\n<li><a href=\"#what-is\">Ce este Mirago?<\/a><\/li>\n<li><a href=\"#how-it-works\">Cum func\u021bioneaz\u0103 mirabegron<\/a><\/li>\n<li><a href=\"#uses\">C\u00e2nd se utilizeaz\u0103 mirabegron<\/a><\/li>\n<li><a href=\"#how-to-take\">Dozaj \u0219i mod de administrare<\/a><\/li>\n<li><a href=\"#side-effects\">Efecte secundare \u0219i siguran\u021b\u0103<\/a><\/li>\n<li><a href=\"#bp-monitoring\">Monitorizarea tensiunii arteriale<\/a><\/li>\n<li><a href=\"#contraindications\">Contraindica\u021bii \u0219i avertiz\u0103ri<\/a><\/li>\n<li><a href=\"#interactions\">Interac\u021biuni medicamentoase<\/a><\/li>\n<li><a href=\"#alternatives\">Mirabegron vs medicamente anticholinergice pentru OAB<\/a><\/li>\n<li><a href=\"#storage\">Depozitare \u0219i termen de valabilitate<\/a><\/li>\n<li><a href=\"#faq\">\u00centreb\u0103ri frecvente<\/a><\/li>\n<\/ul>\n<\/div>\n<h2 id=\"what-is\" class=\"wp-block-heading\">Ce este Mirago?<\/h2>\n<p>Mirago este un brand de <strong>comprimat cu eliberare prelungit\u0103 mirabegron 25 mg<\/strong>. Mirabegron este primul \u2014 \u0219i r\u0103m\u00e2ne principalul \u2014 agonist al receptorului \u03b23-adrenergic pentru tratamentul vezicii urinare hiperactive. Denumit interna\u021bional <strong>Myrbetriq (SUA), Betmiga (UK\/UE), Mirabegron generic<\/strong>. Dimensiuni de ambalaj disponibile la MedsBase: 30, 60, 90 sau 180 de comprimate.<\/p>\n<h2 id=\"how-it-works\" class=\"wp-block-heading\">Cum func\u021bioneaz\u0103 mirabegron<\/h2>\n<p>Mu\u0219chiul detrusor al vezicii urinare are at\u00e2t <strong>contractil<\/strong> (receptori M3 muscarinici pentru acetilcolin\u0103) c\u00e2t \u0219i <strong>relaxant<\/strong> (receptori adrenergici \u03b23) intr\u0103ri. \u00cen timpul umplerii vezicii, activitatea nervoas\u0103 simpatic\u0103 stimuleaz\u0103 receptorii \u03b23, permi\u021b\u00e2nd detrusorului s\u0103 se relaxeze \u0219i vezicii s\u0103 acomodeze volume cresc\u0103toare f\u0103r\u0103 a declan\u0219a urgen\u021b\u0103 sau contrac\u021bie.<\/p>\n<p>\u00cen vezica hiperactiv\u0103, aceast\u0103 relaxare \u00een faza de umplere este afectat\u0103 \u2014 detrusorul se contract\u0103 nepotrivit la volume mici, produc\u00e2nd urgen\u021b\u0103, frecven\u021b\u0103 \u0219i incontinen\u021b\u0103 de urgen\u021b\u0103. <strong>Mirabegron este un agonist selectiv \u03b23<\/strong>: amplific\u0103 semnalul natural de relaxare \u00een timpul umplerii, cresc\u00e2nd capacitatea func\u021bional\u0103 a vezicii \u0219i reduc\u00e2nd triada urgen\u021b\u0103-frecven\u021b\u0103-incontinen\u021b\u0103.<\/p>\n<p>Crucial, mirabegron NU blocheaz\u0103 receptorii muscarinici de acetilcolin\u0103 \u2014 astfel nu provoac\u0103 gur\u0103 uscat\u0103, constipa\u021bie, vedere \u00eence\u021bo\u0219at\u0103, reten\u021bie urinar\u0103, \u00eencetinire cognitiv\u0103 sau riscul de c\u0103dere anticolinergic care au limitat \u00eentotdeauna oxibutinina, tolterodina, solifenacina \u0219i alte medicamente antimuscarinice pentru vezic\u0103 hiperactiv\u0103. Acest beneficiu este cel mai relevant la adul\u021bii \u00een v\u00e2rst\u0103 \u0219i la pacien\u021bii care iau multiple medicamente anticolinergice.<\/p>\n<h2 id=\"uses\" class=\"wp-block-heading\">C\u00e2nd se utilizeaz\u0103 mirabegron<\/h2>\n<ul>\n<li><strong>Sindromul vezicii hiperactive (OAB)<\/strong> \u2014 simptome de urgen\u021b\u0103, frecven\u021b\u0103, nocturie, cu sau f\u0103r\u0103 incontinen\u021b\u0103 de urgen\u021b\u0103, la adul\u021bi. Indica\u021bia autorizat\u0103.<\/li>\n<li><strong>Hiperactivitate detrusor neurogen\u0103<\/strong> la adul\u021bi \u0219i copii cu v\u00e2rsta de 3+ (autoriza\u021bia Myrbetriq SUA)<\/li>\n<li><strong>Vezic\u0103 hiperactiv\u0103 la adul\u021bii \u00een v\u00e2rst\u0103<\/strong> \u2014 din ce \u00een ce mai preferat \u00een locul anticolinergicilor datorit\u0103 absen\u021bei efectelor secundare cognitive \u0219i de risc de c\u0103dere (American Geriatrics Society Beers Criteria 2023)<\/li>\n<li><strong>OAB la pacien\u021bii care iau multiple medicamente anticholinergice<\/strong> (stabilizatoare de dispozi\u021bie, antipsihotice, medicamente pentru alergii, ajutoare pentru somn) \u2014 evit\u0103 acumularea de sarcin\u0103 anticholinergic\u0103<\/li>\n<li><strong>Terapie combinat\u0103 cu solifenacin\u0103<\/strong> \u2014 dovezi recente sus\u021bin ad\u0103ugarea mirabegronului la o doz\u0103 mic\u0103 de anticholinergic pentru simptomele refractare de OAB (studiu BESIDE)<\/li>\n<\/ul>\n<h2 id=\"how-to-take\" class=\"wp-block-heading\">Dozaj \u0219i mod de administrare<\/h2>\n<ul>\n<li><strong>Doza de \u00eenceput: 25 mg o dat\u0103 pe zi<\/strong> (o tablet\u0103 de Mirago). Lua\u021bi cu sau f\u0103r\u0103 m\u00e2ncare, aproximativ la aceea\u0219i or\u0103 \u00een fiecare zi.<\/li>\n<li><strong>\u00cenghi\u021bi\u021bi \u00eentreag\u0103<\/strong> cu ap\u0103 \u2014 nu mesteca\u021bi, nu desp\u0103r\u021bi\u021bi \u0219i nu zdrobi\u021bi (formulare cu eliberare prelungit\u0103)<\/li>\n<li>Efectul se dezvolt\u0103 treptat pe parcursul a 4-8 s\u0103pt\u0103m\u00e2ni. Dac\u0103 r\u0103spunsul este insuficient dup\u0103 4-8 s\u0103pt\u0103m\u00e2ni, doza poate fi crescut\u0103 la <strong>50 mg o dat\u0103 pe zi<\/strong>.<\/li>\n<li><strong>Afectare renal\u0103:<\/strong> u\u0219oar\u0103 p\u00e2n\u0103 la moderat\u0103 \u2014 dozare standard. Sever\u0103 (eGFR 15-29) \u2014 maxim 25 mg\/zi. Stadiu terminal\/dializ\u0103 \u2014 nu este recomandat.<\/li>\n<li><strong>Afectare hepatic\u0103:<\/strong> u\u0219oar\u0103 \u2014 dozare standard. Moderat\u0103 (Child-Pugh B) \u2014 maxim 25 mg\/zi. Sever\u0103 (Child-Pugh C) \u2014 nu este recomandat.<\/li>\n<li><strong>V\u00e2rstnici:<\/strong> dozare standard (acesta este grupul de v\u00e2rst\u0103 preferat)<\/li>\n<li>Dac\u0103 uita\u021bi o doz\u0103, lua\u021bi-o c\u00e2t mai cur\u00e2nd posibil, cu excep\u021bia cazului \u00een care mai sunt mai pu\u021bin de 6 ore p\u00e2n\u0103 la urm\u0103toarea doz\u0103. Nu lua\u021bi o doz\u0103 dubl\u0103.<\/li>\n<\/ul>\n<h2 id=\"side-effects\" class=\"wp-block-heading\">Efecte secundare \u0219i siguran\u021b\u0103<\/h2>\n<ul>\n<li><strong>Frecvente (1 din 10):<\/strong> cre\u0219tere mic\u0103 a frecven\u021bei cardiace (~1 bpm), cre\u0219tere mic\u0103 a tensiunii arteriale (~1 mmHg), infec\u021bie a tractului urinar, cefalee, nazofaringit\u0103, gur\u0103 uscat\u0103 (mult mai pu\u021bin frecvente dec\u00e2t cu anticholinergicele)<\/li>\n<li><strong>Mai pu\u021bin frecvente:<\/strong> palpita\u021bii, fibrila\u021bie atrial\u0103, constipa\u021bie, grea\u021b\u0103, durere articular\u0103 sau muscular\u0103, erup\u021bie cutanat\u0103, ame\u021beli<\/li>\n<li><strong>Rare:<\/strong> angioedem (umflarea fe\u021bei, buzelor, limbii) \u2014 OPRI\u021aI imediat \u0219i c\u0103uta\u021bi \u00eengrijire de urgen\u021b\u0103, reten\u021bie urinar\u0103 (\u00een special la pacien\u021bii cu obstruc\u021bie a ie\u0219irii vezicii), sindromul Stevens-Johnson<\/li>\n<li><strong>NU este tipic:<\/strong> efecte secundare anticolinergice \u2014 gur\u0103 uscat\u0103 minimal\u0103, f\u0103r\u0103 constipa\u021bie semnificativ\u0103, f\u0103r\u0103 \u00eencetinire cognitiv\u0103, f\u0103r\u0103 contribu\u021bie la riscul de c\u0103dere<\/li>\n<\/ul>\n<h2 id=\"bp-monitoring\" class=\"wp-block-heading\">Monitorizarea tensiunii arteriale<\/h2>\n<p>Mirabegron determin\u0103 o cre\u0219tere mic\u0103, dar m\u0103surabil\u0103 a tensiunii arteriale (de obicei 1-3 mmHg sistolic\u0103 la doze standard, u\u0219or mai mult la 50 mg). Pentru majoritatea pacien\u021bilor, acest lucru este clinic irelevant. Pentru pacien\u021bii cu hipertensiune preexistent\u0103:<\/p>\n<ul>\n<li>M\u0103sura\u021bi tensiunea arterial\u0103 ini\u021bial\u0103 \u00eenainte de \u00eenceperea tratamentului<\/li>\n<li>Re-m\u0103sura\u021bi la 4-6 s\u0103pt\u0103m\u00e2ni \u0219i la orice cre\u0219tere de doz\u0103<\/li>\n<li><strong>Nu \u00eencepe\u021bi mirabegron \u00een caz de hipertensiune sever\u0103 necontrolat\u0103<\/strong> (sistolic\u0103 &gt;180 SAU diastolic\u0103 &gt;110)<\/li>\n<li>Dac\u0103 tensiunea arterial\u0103 cre\u0219te semnificativ sub mirabegron, optimiza\u021bi terapia antihipertensiv\u0103 sau trece\u021bi la un medicament anticolinergic pentru vezic\u0103 hiperactiv\u0103<\/li>\n<\/ul>\n<h2 id=\"contraindications\" class=\"wp-block-heading\">Contraindica\u021bii \u0219i avertiz\u0103ri<\/h2>\n<p><strong>Nu lua\u021bi mirabegron dac\u0103 ave\u021bi:<\/strong><\/p>\n<ul>\n<li>Hipertensiune sever\u0103 necontrolat\u0103 (TAS \u2265180 SAU TAD \u2265110)<\/li>\n<li>Boal\u0103 renal\u0103 \u00een stadiu terminal (TFG &lt;15) sau la dializ\u0103<\/li>\n<li>Afectare hepatic\u0103 sever\u0103 (Child-Pugh C)<\/li>\n<li>Hipersensibilitate la mirabegron<\/li>\n<li>Substrate CYP2D6 puternice cu indice terapeutic \u00eengust (precau\u021bie; mirabegron este un inhibitor moderat al CYP2D6)<\/li>\n<\/ul>\n<p><strong>Folosi\u021bi cu precau\u021bie dac\u0103 ave\u021bi:<\/strong> obstruc\u021bie a orificiului vezical (risc de reten\u021bie urinar\u0103, mai ales atunci c\u00e2nd este combinat cu medicamente anticolinergice pentru vezic\u0103 hiperactiv\u0103), prelungire QT congenital\u0103 sau dob\u00e2ndit\u0103, hipertensiune controlat\u0103, antecedente de angioedem.<\/p>\n<h2 id=\"interactions\" class=\"wp-block-heading\">Interac\u021biuni medicamentoase<\/h2>\n<ul>\n<li><strong>Substrate CYP2D6 puternice cu indice terapeutic \u00eengust<\/strong> (metoprolol, propafenon\u0103, flecainid\u0103, desipramin\u0103, tioridazin\u0103) \u2014 mirabegronul este un inhibitor moderat al CYP2D6, poate cre\u0219te nivelurile plasmatice; poate fi necesar\u0103 ajustarea dozei<\/li>\n<li><strong>Digoxin\u0103<\/strong> \u2014 mirabegronul cre\u0219te moderat nivelurile de digoxin\u0103; monitoriza\u021bi nivelurile de digoxin\u0103 \u0219i lua\u021bi \u00een considerare reducerea dozei<\/li>\n<li><strong>Warfarin<\/strong> \u2014 interac\u021biune minim\u0103 la doze standard; se recomand\u0103 verificarea INR dup\u0103 \u00eenceperea tratamentului<\/li>\n<li><strong>Medicamente anticholinergice pentru OAB<\/strong> (solifenacin\u0103, tolterodin\u0103, oxibutinin\u0103) \u2014 combina\u021bia este bine sus\u021binut\u0103 (studiu BESIDE) pentru OAB refractar; monitoriza\u021bi pentru reten\u021bie urinar\u0103<\/li>\n<li><strong>Inhibitori puternici ai CYP3A4<\/strong> (ketoconazol, ritonavir) \u2014 cresc moderat expunerea la mirabegron; reduce\u021bi la 25 mg\/zi dac\u0103 se combin\u0103<\/li>\n<\/ul>\n<h2 id=\"alternatives\" class=\"wp-block-heading\">Mirabegron vs medicamente anticholinergice pentru OAB<\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:14px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Caracteristic\u0103<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Mirabegron (agonist \u03b23)<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Oxibutinin\u0103 \/ tolterodin\u0103 \/ solifenacin\u0103 (anticholinergic)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Eficacitate<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Echivalent<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Echivalent<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Gur\u0103 uscat\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Minim\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Frecvent (10-30%)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Constipa\u021bie<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Nu<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Frecvente<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Efecte cognitive la v\u00e2rstnici<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Nu<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Da \u2014 risc de c\u0103deri, delir, demen\u021b\u0103 (Criteriile Beers)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Tensiune arterial\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Cre\u0219tere mic\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">De obicei neutru<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Cost<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Mai scump (nou)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Mai ieftin (generice)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Alte pagini relevante pe acest site: <a href=\"https:\/\/medsbase.com\/ro\/oxyspas\/\"><strong>Oxyspas (oxibutinin\u0103)<\/strong><\/a>, <a href=\"https:\/\/medsbase.com\/ro\/roliten\/\"><strong>Roliten (tolterodin\u0103 IR)<\/strong><\/a>, <a href=\"https:\/\/medsbase.com\/ro\/terol-la\/\"><strong>Terol LA (tolterodin\u0103 cu eliberare prelungit\u0103)<\/strong><\/a>, <a href=\"https:\/\/medsbase.com\/ro\/urispas\/\"><strong>Urispas (flavoxat antispastic)<\/strong><\/a>.<\/p>\n<h2 id=\"storage\" class=\"wp-block-heading\">Depozitare \u0219i termen de valabilitate<\/h2>\n<p>P\u0103stra\u021bi comprimatele Mirago la temperaturi sub 25\u00b0C \u00een blisterul original. Proteja\u021bi de umiditate \u0219i lumin\u0103. Depozita\u021bi \u00een loc inaccesibil copiilor. Nu utiliza\u021bi dup\u0103 data de expirare tip\u0103rit\u0103 pe cutie.<\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">C\u00e2t de repede ac\u021bioneaz\u0103 mirabegronul?<\/h3>\n<p>\u00cembun\u0103t\u0103\u021biri modeste ale urgen\u021bei \u0219i frecven\u021bei se observ\u0103 de obicei \u00een 1-2 s\u0103pt\u0103m\u00e2ni; efectul complet se dezvolt\u0103 \u00een 4-8 s\u0103pt\u0103m\u00e2ni. Dac\u0103 simptomele nu s-au ameliorat semnificativ dup\u0103 8 s\u0103pt\u0103m\u00e2ni la doza de 25 mg, doza poate fi crescut\u0103 la 50 mg\/zi; dac\u0103 r\u0103m\u00e2ne inadecvat\u0103, ar trebui luate \u00een considerare medicamente alternative (anticolinergice pentru OAB sau terapie combinat\u0103).<\/p>\n<h3 class=\"wp-block-heading\">De ce este preferat mirabegronul pentru adul\u021bii \u00een v\u00e2rst\u0103?<\/h3>\n<p>Criteriile Beers 2023 ale Societ\u0103\u021bii Americane de Geriatrie clasific\u0103 toate medicamentele anticolinergice pentru OAB ca \u201cpoten\u021bial inadecvate\u201d la adul\u021bii cu v\u00e2rsta de 65+ ani din cauza \u00eenc\u0103rc\u0103turii anticolinergice cumulative \u2014 asociat\u0103 cu risc crescut de c\u0103deri, delir, declin cognitiv \u0219i posibil risc pe termen lung de demen\u021b\u0103. Mirabegronul nu este anticolinergic, evit\u0103 aceste riscuri \u0219i, prin urmare, este medicamentul de prim\u0103 linie preferat pentru OAB la pacien\u021bii \u00een v\u00e2rst\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Va cre\u0219te mirabegron tensiunea arterial\u0103?<\/h3>\n<p>Mirabegron determin\u0103 o u\u0219oar\u0103 cre\u0219tere medie a tensiunii arteriale (1-3 mmHg sistolic\u0103 la doza de 25 mg, u\u0219or mai mult la 50 mg) \u2014 de obicei f\u0103r\u0103 relevan\u021b\u0103 clinic\u0103. Pacien\u021bii cu hipertensiune controlat\u0103 pot lua medicamentul cu monitorizare periodic\u0103 a TA. Este contraindicat \u00een hipertensiune sever\u0103 necontrolat\u0103 (\u2265180\/110).<\/p>\n<h3 class=\"wp-block-heading\">Poate fi combinat mirabegron cu oxibutinin\u0103 sau solifenacin\u0103?<\/h3>\n<p>Da \u2014 aceast\u0103 combina\u021bie este bine documentat\u0103 (studiu BESIDE a ar\u0103tat c\u0103 solifenacin\u0103 5 mg + mirabegron 50 mg aduce o reducere semnificativ mai mare a simptomelor fa\u021b\u0103 de monoterapie \u00een OAB refractar). Combina\u021bia necesit\u0103 monitorizare atent\u0103 pentru reten\u021bie urinar\u0103, \u00een special la b\u0103rba\u021bii cu obstruc\u021bie de tract urinar inferior.<\/p>\n<h3 class=\"wp-block-heading\">Pot lua mirabegron concomitent cu antidepresive?<\/h3>\n<p>Mirabegron este un inhibitor moderat al CYP2D6, astfel poate cre\u0219te u\u0219or nivelurile plasmatice ale unor antidepresive triciclice (desipramin\u0103, nortriptilin\u0103) \u0219i beta-blocante (metoprolol). Pentru majoritatea pacien\u021bilor sub tratament antidepresiv acest efect nu este semnificativ clinic, dar discuta\u021bi cu medicul dac\u0103 lua\u021bi metoprolol, propafenon\u0103, flecainid\u0103 sau tioridazin\u0103 \u2014 acestea pot necesita ajustare de doz\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Cauzeaz\u0103 mirabegron gur\u0103 uscat\u0103 ca oxibutinina?<\/h3>\n<p>Minim \u2014 mirabegron nu blocheaz\u0103 receptorii acetilcolinici, astfel gura uscat\u0103 este neobi\u0219nuit\u0103 \u0219i de obicei u\u0219oar\u0103. Acesta este principalul avantaj practic fa\u021b\u0103 de medicamentele anticholinergice pentru OAB (oxibutinin\u0103, tolterodin\u0103, solifenacin\u0103), unde gura uscat\u0103 afecteaz\u0103 10-30% din utilizatori \u0219i este motivul principal de \u00eentrerupere a tratamentului.<\/p>\n<h3 class=\"wp-block-heading\">Va ajuta mirabegron incontinen\u021ba mea de urgen\u021b\u0103?<\/h3>\n<p>Da \u2014 studiile clinice arat\u0103 c\u0103 mirabegron reduce num\u0103rul mediu de episoade de incontinen\u021b\u0103 pe s\u0103pt\u0103m\u00e2n\u0103 cu 40-60%, similar cu anticholinergicele. Ca la toate medicamentele pentru OAB, r\u0103spunsul variaz\u0103; unii pacien\u021bi \u00eenregistreaz\u0103 \u00eembun\u0103t\u0103\u021biri mari, al\u021bii modeste. Un trial de 4-8 s\u0103pt\u0103m\u00e2ni este rezonabil pentru evaluarea r\u0103spunsului.<\/p>\n<h3 class=\"wp-block-heading\">Poate fi luat mirabegron pe termen lung?<\/h3>\n<p>Da \u2014 OAB este de obicei o afec\u021biune cronic\u0103 \u0219i mirabegron este destinat utiliz\u0103rii pe termen lung. Se recomand\u0103 evaluare periodic\u0103 (anual\u0103) pentru confirmarea beneficiului continuu \u0219i verificarea TA \u0219i func\u021biei renale.<\/p>\n<h3 class=\"wp-block-heading\">Unde pot comanda Mirago online?<\/h3>\n<p>Pute\u021bi comanda comprimate Mirago 25 mg de la MedsBase \u00een cutii de 30, 60, 90 sau 180 de comprimate. Comenzile se expediaz\u0103 \u00een \u00eentreaga lume \u00een ambalaje discrete. Mirabegron este sub supraveghere medical\u0103 specializat\u0103 la nivel global.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\">\n<strong>\u2695 Dezaprobare medical\u0103.<\/strong> Aceast\u0103 pagin\u0103 are scop informativ \u0219i nu \u00eenlocuie\u0219te sfatul medical al unui profesionist calificat \u00een domeniul s\u0103n\u0103t\u0103\u021bii. Consulta\u021bi \u00eentotdeauna medicul sau farmacistul \u00eenainte de a \u00eencepe, modifica sau \u00eentrerupe orice tratament pentru simptome urinare sau de prostat\u0103 \u2014 acestea pot fi semnele timpurii ale unor afec\u021biuni (infec\u021bie urinar\u0103, cancer de prostat\u0103, pietre vezicale) care necesit\u0103 diagnostic \u0219i tratament \u021bintit, nu doar ameliorare simptomatic\u0103. MedsBase nu ofer\u0103 diagnostic, prescrip\u021bie sau recomand\u0103ri clinice.\n<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Alternative conexe<\/h3>\n<p>Alte produse din <strong>S\u0103n\u0103tate general\u0103<\/strong> pe care clien\u021bii le vizualizeaz\u0103 de asemenea:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/cynomycin\/\">Cynomycin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/alfusin-tab\/\">Alfusin Tab<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/levoflox\/\">Levoflox<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/lurafic\/\">Lurafic<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/omez-d\/\">Omez D<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Amelioreaz\u0103 simptomele vezicale<br \/>\n\u2705 Reduce frecven\u021ba urinar\u0103<br \/>\n\u2705 Diminueaz\u0103 incontinen\u021ba de urgen\u021b\u0103<br \/>\n\u2705 \u00cembun\u0103t\u0103\u021be\u0219te capacitatea vezical\u0103<br \/>\n\u2705 Spor\u0103 controlul urinar<\/p>\n<p>Mirago con\u021bine Mirabegron.<\/p>","protected":false},"featured_media":59090,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3614,3141,3342],"product_tag":[4624,4625],"class_list":{"0":"post-59089","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-bladder-prostate","7":"product_cat-category-overview","8":"product_cat-general-health","9":"product_tag-mirabegron","10":"product_tag-mirago","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/59089","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=59089"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/59090"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=59089"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=59089"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=59089"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=59089"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}